Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis

Commons RJ. et al, (2024), The Lancet Infectious Diseases, 24, 172 - 183

Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: a descriptive epidemiological study.

Florimond C. et al, (2024), The Lancet. Infectious diseases, 24, 161 - 171

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis

Rajasekhar M. et al, (2024), The Lancet Infectious Diseases, 24, 184 - 195

Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Mehdipour P. et al, (2023), Malaria Journal, 22

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency

Taylor WRJ. et al, (2023), PLOS Neglected Tropical Diseases, 17, e0011522 - e0011522

The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial

Thriemer K. et al, (2023), BMC Medical Research Methodology, 23

Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual patient data meta-analysis

Wynberg E. et al, (2023), Malaria Journal, 22

Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis

Dahal P. et al, (2022), Malaria Journal, 21

Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data

Mansoor R. et al, (2022), BMC Medicine, 20

An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.

MalariaGEN None. et al, (2022), Wellcome open research, 7

Rolling out the radical cure for vivax malaria in Asia: a qualitative study among policy makers and stakeholders.

Adhikari B. et al, (2021), Malaria journal, 20

Protective effect of Mediterranean-type glucose-6-phosphate dehydrogenase deficiency against Plasmodium vivax malaria

Awab GR. et al, (2021), eLife, 10

Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017.

Rakmark K. et al, (2020), Malaria journal, 19

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines

Newton PN. et al, (2020), The Lancet Global Health, 8, e754 - e755

Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis

(2019), Malaria Journal, 18

Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data

Devine A. et al, (2019), Bulletin of the World Health Organization, 97, 828 - 836

The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Commons RJ. et al, (2019), BMC Medicine, 17

The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis

Commons RJ. et al, (2019), PLOS Medicine, 16, e1002928 - e1002928

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial

Taylor WRJ. et al, (2019), The Lancet, 394, 929 - 938

The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis

Commons RJ. et al, (2018), The Lancet Infectious Diseases, 18, 1025 - 1034

Load More

Include forthcoming?